James Pettay

Discrepancies in Clinical Laboratory Testing of Eligibility for Trastuzumab Therapy: Apparent Immunohistochemical False-Positives Do Not Get the Message

Raymond R. Tubbs, James Pettay, Patrick C. Roche et al. · Journal of Clinical Oncology · 2001 · 363 citations

Medicine, Oncology, Pathology +16

Multitarget Fluorescence In Situ Hybridization Assay Detects Transitional Cell Carcinoma in the Majority of Patients with Bladder Cancer and Atypical or Negative Urine Cytology

Marek Skacel, Mona Fahmy, Jennifer Brainard et al. · The Journal of Urology · 2003 · 305 citations

Medicine, Oncology, Pathology +14

Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor

Barbara P. Barna, James Pettay, Gene H. Barnett et al. · Journal of Neuroimmunology · 1994 · 142 citations

Life Sciences, Cell Biology, Immunology +17

Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)

Hiroaki Nitta, Beatrice Hauss‐Wegrzyniak, Megan Lehrkamp et al. · Diagnostic Pathology · 2008 · 111 citations · Full text

Medicine, Molecular Biology, Oncology +17

Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma

Bettina G. Papouchado, Jonathan Myles, Ricardo V. Lloyd et al. · The American Journal of Surgical Pathology · 2010 · 99 citations

Medicine, Oncology, Pathology +17